Fact-checked by Grok 2 weeks ago

Bloating

Bloating is a common symptom involving a sensation of fullness, tightness, pressure, or swelling in the , often accompanied by visible distention in about half of cases. This discomfort arises primarily from excess gas accumulation in the , though it can also stem from fluid retention, , or other factors, and is typically temporary but may recur. While bloating affects people of all ages, it is more prevalent in women, particularly during menstrual cycles due to hormonal influences. In the general , bloating occurs occasionally in 10–25% of healthy individuals, but it is far more frequent among those with functional gastrointestinal disorders, impacting 66–90% of patients with (IBS). Associated symptoms may include , , (typically 8–25 times daily as normal), and altered bowel habits such as or . According to the Rome IV criteria, functional abdominal bloating/distension is diagnosed when there is recurrent bloating and/or distension occurring on average at least 1 day per week in the last 3 months, with symptom onset at least 6 months prior to , and insufficient criteria for a diagnosis of another of gut-brain that explains the symptoms. Common causes of bloating include (swallowing air from habits like or eating quickly), bacterial fermentation of undigested carbohydrates in the colon, and dietary triggers such as or intolerance. Other contributors encompass (SIBO), impaired gut motility, visceral hypersensitivity, and conditions like or hormonal fluctuations during perimenopause. Pathophysiologically, it involves disrupted gas transit, abnormal abdominal reflexes, and altered gut-brain s, which can amplify the perception of discomfort. Although often benign and self-resolving, persistent or severe bloating warrants medical evaluation to rule out underlying issues such as celiac disease, , or , particularly if accompanied by unexplained , fever, , or blood in the stool.

Overview

Definition

Bloating is defined medically as a subjective sensation of increased abdominal pressure, fullness, or distension, often described by patients as a feeling of tightness, swelling, or discomfort in the without a corresponding measurable increase in abdominal girth. This distinguishes it from objective , which involves visible or quantifiable enlargement of the due to factors such as fluid accumulation, organ enlargement, or excess gas volume. The sensation is inherently personal and varies in intensity, commonly occurring postprandially—after eating—or intermittently throughout the day, and it may persist for hours without resolution. Bloating differs from related gastrointestinal terms in its focus on perceived volume increase and discomfort rather than other mechanisms; for instance, unlike , which involves the expulsion of intestinal gas, bloating centers on the internal of trapped gas or without passage. Similarly, it is distinct from , which implies sharp or cramping sensations, whereas bloating highlights a more diffuse, pressure-like unease often without nociceptive involvement. This subjective emphasis underscores bloating's challenge in clinical assessment, relying heavily on patient-reported descriptors rather than objective metrics.

Epidemiology

Bloating is a prevalent gastrointestinal symptom worldwide, affecting approximately 10-25% of healthy adults on a regular basis. In the general population, surveys indicate that nearly 18% experience bloating at least once per week, with rates ranging from 6-13% in community-based studies to as high as 20% in some populations. Among individuals with gastrointestinal disorders, such as functional gastrointestinal disorders (FGIDs), the prevalence rises significantly, impacting up to 76-90% of patients. For instance, bloating occurs in 82.5% of those with (IBS), where it ranks as one of the most common symptoms. Prevalence exhibits notable demographic patterns, particularly a higher occurrence in women at a ratio of approximately 2:1 compared to men (23.4% in women versus 12.2% in men globally). This disparity is attributed in part to hormonal influences, with premenstrual exacerbation reported by up to 73% of menstruating individuals experiencing gastrointestinal symptoms like bloating during the . Bloating is more common in populations, where dietary factors such as high intake of processed foods and contribute to its incidence. Recent studies from the have documented an increase in bloating and related digestive disorders, linked to post-COVID-19 gut and pandemic-related stress, with disorders of gut-brain interaction showing elevated post-pandemic. Key risk factors include , with prevalence peaking in younger to middle-aged adults (typically 20-50 years) and decreasing in older groups. Gender-related vulnerabilities, as noted, amplify in females, particularly around menstrual cycles. Comorbidities such as further elevate susceptibility, with individuals having a BMI greater than 30 facing a heightened of gastrointestinal symptoms including bloating due to altered gut and composition. Geographic variations highlight higher reporting in industrialized and Latin American regions (up to 20-30% ) compared to (around 11%), potentially influenced by dietary patterns and healthcare access. In low-resource settings, bloating may be underreported owing to cultural and limited medical consultation for non-acute symptoms.

Clinical Presentation

Symptoms

Bloating is primarily characterized by a subjective of abdominal fullness, tightness, or swelling, which patients often describe as an uncomfortable pressure within the . This symptom typically worsens after meals due to increased gastric volume and gas accumulation, and it may persist for hours to days, varying in intensity based on individual factors. Secondary symptoms frequently accompany the primary sensation and include excessive (eructation), , and mild abdominal cramping, which arise from altered gas transit or visceral hypersensitivity. Visible , an objective increase in abdominal girth, occurs in approximately 52% of cases among patients with (IBS) who experience bloating. Nocturnal exacerbation of symptoms is uncommon in isolated bloating but may occur if linked to underlying gastrointestinal disorders. Symptom patterns of bloating can manifest as intermittent episodes, often triggered by specific meals or stressors, or as chronic complaints persisting for more than 3 months, meeting criteria for functional abdominal bloating in clinical contexts. Severity is commonly evaluated using validated scales, such as the bloating subscale of the Patient Assessment of Gastrointestinal Symptom Severity (PAGI-SYM) , which quantifies discomfort intensity on a for research and clinical monitoring. The presence of bloating often impairs , with over 54% of affected individuals reporting interference in daily activities, disrupted , or challenges with clothing fit due to perceived or actual distension. This functional burden is compounded by psychological effects, including heightened anxiety in more than 40% of patients with associated functional gastrointestinal disorders, correlating with overall symptom severity and reduced scores.

Differential Diagnosis

Bloating, characterized by a sensation of abdominal fullness or increased girth, often overlaps with symptoms of various gastrointestinal and systemic disorders, necessitating a to distinguish functional from organic causes. Common mimics include (IBS), where bloating is a predominant and recurrent symptom in 66–90% of patients, often accompanied by altered bowel habits and relieved by or passage of flatus; chronic constipation, marked by hard stools and gas retention due to slow transit; and (GERD), which may present with bloating alongside reflux symptoms, particularly in cases of gas-bloat syndrome following anti-reflux surgery. Red-flag conditions that warrant urgent evaluation include , which can manifest as persistent, unilateral bloating with pelvic mass; disease, featuring bloating alongside , , and detectable via serologic testing; and (SIBO), indicated by bloating with signs such as and confirmed by breath testing showing early hydrogen rise. Diagnostic clues to differentiate bloating from serious pathologies involve identifying alarm symptoms, such as unexplained exceeding 10%, , , recurrent , nocturnal , or a family history of gastrointestinal , which prompt immediate or . In functional disorders, bloating aligns with Rome IV criteria as a core symptom of functional abdominal bloating/distension, defined by recurrent sensations of fullness, pressure, or trapped gas with or without visible girth increase, occurring on average at least 1 day per week in the last three months with onset at least six months prior, in the absence of criteria for other disorders such as IBS, and is distinguished from mechanical obstructions like bowel blockages where acute pain and predominate.

Pathophysiology

Gas Dynamics

Intestinal gas primarily arises from three sources: swallowed air through , which contributes and oxygen; bacterial in the colon, producing (H₂), (CO₂), and (CH₄); and minimal of gases such as oxygen and CO₂ across the intestinal mucosa from the bloodstream. accounts for gas in the upper gut, often expelled via , while occurs on undigested carbohydrates and fibers, generating the bulk of colonic gas volume. contributes negligibly, typically less than 1% of total gas. Under normal conditions, the contains about 100-200 mL of gas, with daily production ranging from 0.6 to 1.7 liters, primarily expelled as flatus 14-23 times per day. Bloating sensations emerge when gas retention surpasses expulsion capacity, leading to distension without necessarily increasing total gas volume. In the small bowel, gas transit time averages 30-90 minutes, facilitating rapid movement from to via peristaltic propulsion. Slowed disrupts these dynamics, promoting proximal gas pooling in the and segmental distension. This retention is exacerbated by impaired intrinsic reflexes that normally coordinate proximal contraction and distal relaxation for gas propulsion. breath tests measure these dynamics by quantifying bacterial overgrowth, a contributor to excess gas production; a rise in exhaled exceeding 20 parts per million () within 90 minutes post-ingestion indicates small intestinal fermentation. This non-invasive technique tracks peaks from substrate, correlating with transit and overgrowth patterns.

Sensory and Motility Factors

Visceral hypersensitivity plays a central role in amplifying the perception of bloating in patients with functional gastrointestinal disorders, such as (IBS), where internal stimuli that would be innocuous in healthy individuals provoke exaggerated discomfort. This condition is characterized by a lowered for and discomfort in response to gut distension, often linked to central sensitization mechanisms in the brain-gut axis that heighten neural signaling from the viscera. Studies indicate that up to 60% of IBS patients, many of whom report prominent bloating, exhibit this hypersensitivity, distinguishing it from mere gas accumulation. Barostat studies, which measure gut and sensory thresholds through controlled balloon distension, consistently demonstrate reduced discomfort thresholds in affected patients. For instance, rectal barostat assessments in IBS cohorts reveal pain thresholds at significantly lower pressures or volumes compared to healthy controls, with correlating directly with bloating severity rather than distension alone. This perceptual amplification occurs independently of gas volume but can exacerbate symptoms when combined with gas retention in the gut. Central contributes by enhancing spinal and supraspinal processing of visceral signals, leading to a cycle of heightened awareness and discomfort. Motility disturbances further contribute to bloating by impairing the propulsion and clearance of intestinal contents, including gas. Delayed gastric emptying, as seen in , prolongs the retention of food and air in the stomach, fostering a sensation of fullness and bloating; scintigraphic studies show delayed gastric emptying (e.g., >60% retention at 2 hours) in approximately 25% of patients with functional bloating or dyspepsia. Similarly, slowed colonic transit, defined by Rome IV criteria for as infrequent bowel movements alongside prolonged transit (>72 hours via marker studies), reduces gas evacuation and intensifies bloating in IBS-constipation predominant subtypes. Antroduodenal manometry may reveal diminished migrating motor complexes (MMCs), the fasting waves that sweep debris and bacteria from the , in some cases of chronic bloating associated with disorders. The neurological interplay underlying these factors involves dysregulation of the and the broader brain-gut axis, where bidirectional signaling modulates gut sensation and motility. Vagal afferents transmit visceral signals to the , but impaired tone—often due to autonomic imbalance—can heighten hypersensitivity and delay reflexes like gastric accommodation. Stress exacerbates this through activation of the hypothalamic-pituitary-adrenal axis, elevating levels that sensitize nociceptors and disrupt motility, thereby worsening bloating in susceptible individuals. Barostat studies show reduced discomfort thresholds in IBS patients, often 20-30% lower than in healthy controls. These metrics underscore how sensory-motor dyssynchrony, rather than gas alone, drives the symptom's persistence.

Etiology

Dietary Triggers

Dietary triggers of bloating primarily involve foods and beverages that promote excessive gas production, , or air in the . Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs), such as fructans found in and onions or galacto-oligosaccharides (galactans) in beans and , are poorly absorbed in the and reach the colon, where colonic ferment them into , , , and gases. This process contributes to bloating by increasing intraluminal gas volume, as evidenced by elevated levels on breath tests in susceptible individuals following of these carbohydrates. Clinical trials from in the 2010s and 2020s have linked specific high-FODMAP foods to these breath test elevations and demonstrated that a reduces bloating and related symptoms in 50% to 80% of patients with . Other common dietary triggers include in products, which affects approximately 65% to 70% of adults worldwide due to reduced activity, leading to osmotic retention of fluid and bacterial in the colon that produces gas and bloating. , often triggered by high-fructose foods like apples, , or sweetened beverages, similarly causes unabsorbed to draw water into the intestine and undergo colonic , resulting in bloating, , and . Carbonated drinks exacerbate bloating by introducing dissolved gas, which can distend the and contribute to overall gas accumulation in the gut. Meal-related behaviors also play a key role, as consuming large meals or eating rapidly promotes , or excessive air swallowing, which introduces additional air into the digestive system and leads to bloating and . Similarly, a sudden increase in intake, particularly above 30 grams per day from sources like whole grains, fruits, and , can initially worsen bloating through osmotic effects of soluble fiber, which draws water into the bowel, and enhanced bacterial of insoluble fiber residues.

Functional Gastrointestinal Disorders

Functional gastrointestinal disorders (FGIDs), such as (IBS), are among the most common etiologies of chronic bloating, often without identifiable structural abnormalities. Bloating affects 66–90% of individuals with IBS, particularly those with the constipation-predominant subtype (IBS-C), where delayed colonic transit and visceral hypersensitivity contribute to gas retention and . Functional dyspepsia (FD) also frequently presents with bloating, especially postprandial fullness, linked to impaired gastric accommodation and motility disorders. These conditions are diagnosed based on symptom criteria like Rome IV, emphasizing recurrent bloating in the absence of organic disease, with multifactorial origins including gut-brain axis dysregulation and altered composition.

Organic and Systemic Causes

Organic gastrointestinal causes of bloating often involve structural abnormalities or malabsorptive disorders that disrupt normal digestion and gas handling. Celiac disease, an autoimmune reaction to , leads to villous atrophy in the , impairing nutrient absorption and commonly manifesting as bloating due to fermentation of undigested carbohydrates by gut . Bloating is reported in approximately 50% of symptomatic patients with undiagnosed celiac disease. (SIBO) occurs when excessive in the small bowel ferment carbohydrates, producing gas and leading to bloating, with breath tests positive in about 43% of patients with chronic functional abdominal bloating. Gastric outlet obstruction, typically from peptic ulcers or , mechanically impedes gastric emptying, causing postprandial bloating accompanied by and epigastric . Systemic conditions outside the can also produce bloating through indirect effects on motility or fluid dynamics. slows gastrointestinal motility by reducing thyroid hormone influence on function, resulting in and bloating as common symptoms. Ovarian pathologies, such as cysts or malignancies, create a in the , leading to abdominal bloating and distension due to compression of adjacent structures. In advanced , right-sided congestion promotes formation, causing progressive abdominal distension that patients may perceive as bloating. Infectious etiologies contribute to bloating via mucosal and altered gut flora. Giardiasis, caused by the protozoan , infects the and produces symptoms including bloating, , and watery through impaired nutrient absorption and osmotic effects. Clostridium difficile infection, often triggered by antibiotic use, disrupts the colonic , leading to post-antibiotic bloating, cramping, and profuse due to toxin-mediated . Rarer causes include pancreatic insufficiency and , which can mimic more common disorders. results in inadequate production, causing () and subsequent bacterial that generates excess gas and bloating. , prevalent in reproductive-age women, involves ectopic endometrial tissue that can infiltrate pelvic structures, leading to chronic pelvic bloating exacerbated by inflammation and adhesions during .

Diagnosis

Clinical Evaluation

The clinical evaluation of bloating begins with a thorough history taking to characterize the symptom and identify potential underlying causes. Clinicians should inquire about the onset and duration of bloating, noting whether it is acute or , and explore triggers such as specific meals, dietary components like high-fiber foods or carbonated beverages, , or changes in bowel habits. Associated symptoms, including , altered bowel movements, , fever, or nocturnal awakenings, must be documented to differentiate functional from organic etiologies. Validated tools like the Gastrointestinal Symptom Rating Scale (GSRS), a 15-item assessing symptoms such as bloating severity over the past week on a 7-point , can quantify patient-reported experiences and track changes over time. The physical examination focuses on the abdomen to detect signs of distension or complications. Inspection may reveal visible abdominal distension, while palpation assesses for tenderness, guarding, or masses, performed gently to avoid exacerbating discomfort. Auscultation evaluates bowel sounds for hyperactive activity suggesting gas or hypoactive patterns indicating ileus. In cases with constipation or suspected pelvic involvement, a rectal examination is warranted to check for fecal impaction, masses, or anal sphincter tone abnormalities. Assessment for red flags is essential to prioritize urgent evaluation and rule out serious conditions. Key indicators include new-onset bloating in patients over age 50, unexplained , , nocturnal symptoms, or , which necessitate prompt further investigation to exclude or other organic diseases. plays a key role in benign cases, where reassurance about the self-limiting nature of most bloating episodes—often linked to functional gastrointestinal disorders—can alleviate anxiety; studies indicate that the majority of such cases resolve without specific intervention.

Investigative Procedures

If the clinical evaluation suggests an underlying condition or if red flags are present, further diagnostic tests may be indicated. Common investigative procedures include: These procedures are selected based on the patient's history and symptoms to confirm or exclude specific etiologies.

Management

Lifestyle and Dietary Interventions

Regular , particularly 30 minutes of daily such as walking or , can significantly alleviate bloating symptoms by enhancing gastrointestinal and reducing gas accumulation. In a study of individuals with (IBS), a structured exercise program led to a 40% decrease in bloating incidence after completion, attributed to improved colonic transit times and overall gut function. , as a targeted form of exercise, further benefits bloating by modulating the gut-brain axis through reduced activity and increased parasympathetic tone, which helps regulate visceral sensitivity and stress-related digestive disturbances. Adopting mindful eating habits is another key non-pharmacological approach to managing bloating. Consuming smaller, more frequent meals throughout the day, rather than large portions, minimizes gastric distension and reduces the load on digestive processes that contribute to gas production. Chewing food slowly and thoroughly decreases , the swallowing of excess air during meals, which is a common bloating trigger. Similarly, avoiding habits like or using straws limits swallowed air intake, thereby curtailing bloating episodes associated with aerophagia. Dietary protocols offer structured ways to address bloating rooted in fermentable carbohydrates and microbial imbalances. The involves eliminating high-FODMAP foods—such as certain fruits, vegetables, and grains that produce gas through —for 4-6 weeks to identify triggers and relieve symptoms, followed by a systematic reintroduction phase to personalize tolerance and maintain nutritional variety. supplementation with strains, typically at a dose of 10^9 colony-forming units (CFU) per day, supports balance by promoting beneficial growth and reducing gas-forming pathogens in the gut. Stress management techniques are essential, as psychological factors like anxiety can heighten visceral hypersensitivity, exacerbating bloating perception in a substantial portion of affected individuals. Mindfulness-based interventions, such as , and (CBT) effectively mitigate these effects by lowering anxiety levels and improving gut-brain signaling, leading to reduced symptom severity in digestive disorders.

Pharmacological Options

As per the 2025 European Consensus on Functional Bloating and Abdominal Distension, management should be tailored based on predominant symptoms, emphasizing a stepwise approach from modifications to targeted therapies. Pharmacological options for managing bloating primarily target underlying mechanisms such as visceral hypersensitivity, gas accumulation, impaired , and microbial overgrowth, with treatments selected based on the predominant etiology like (IBS) or (SIBO). These agents are typically considered when non-pharmacological approaches prove insufficient, focusing on symptom relief rather than cure. Antispasmodics, including and dicyclomine, are agents used to alleviate bloating associated with disturbances in conditions like IBS by relaxing and reducing intestinal spasms. Typical dosing for dicyclomine is 20 mg orally four times daily, which may be increased to 40 mg four times daily if tolerated, while is administered sublingually or orally at 0.125-0.25 mg every four hours as needed. Randomized controlled trials have demonstrated that these agents improve overall IBS symptoms, including and bloating, compared to , with dicyclomine showing superiority in reducing distention and cramping in up to 82% of patients versus 55% on . However, evidence quality is moderate due to small sample sizes and short-term follow-up, and side effects like dry mouth may limit use. Gas-relief agents address bloating by disrupting foam and facilitating gas expulsion. Simethicone, an , works by lowering to disperse gas bubbles in the gut, with a standard dose of 125 mg taken orally after meals and at bedtime, up to 500 mg daily. Clinical studies indicate it provides relief from postprandial bloating and fullness, particularly in patients with or dietary gas triggers. Alpha-galactosidase (e.g., Beano), an supplement, prevents gas formation from fermentable carbohydrates like beans by hydrolyzing oligosaccharides; it is dosed as 1-2 tablets (containing 300-600 units of enzyme activity) before meals. Double-blind trials have shown reductions in flatulence events and bloating in some patients, though effects vary and are not always statistically significant for bloating. Prokinetics enhance gastrointestinal to mitigate bloating linked to delayed gastric emptying or constipation-predominant IBS (IBS-C). Metoclopramide, a , promotes gastric emptying at a dose of 10 mg orally three times daily before meals, but its use is restricted to short-term (up to 12 weeks) due to risks of and other extrapyramidal effects. Guidelines recommend it for gastroparesis-related bloating, where it improves symptoms in approximately 60-70% of patients, though evidence for bloating specifically is limited by side effect concerns. , a guanylate cyclase-C agonist, stimulates intestinal fluid secretion and transit at 290 mcg orally once daily for IBS-C; phase 3 trials report significant reductions in bloating scores compared to (mean change of approximately 0.8-0.9 points greater on an 11-point scale) alongside improved bowel frequency. Other agents target constipation or microbial factors contributing to bloating. Osmotic laxatives like (PEG) 3350 at 17 g daily dissolved in liquid alleviate bloating from chronic by increasing stool water content and softening feces; randomized trials confirm reductions in bloating and abdominal discomfort in patients with idiopathic . For suspected SIBO, the non-absorbable antibiotic is administered at 550 mg orally three times daily for 14 days, achieving bacterial eradication rates of 50-70% and symptom improvement, including bloating relief, in IBS patients with methane-positive breath tests. Repeat courses may be needed for recurrence, with monitoring for resistance.

Prevention

Prophylactic Habits

Maintaining adequate is a foundational prophylactic for preventing bloating, as it supports digestive and reduces the risk of , a common precursor to . Health authorities recommend consuming 2 to 3 liters of daily, depending on individual factors such as activity level and climate, to soften and facilitate smoother gastrointestinal . Insufficient fluid intake can exacerbate water retention and gas buildup, whereas consistent promotes overall gut without introducing additional irritants. Adopting proper during and after meals further aids in preventing bloating by leveraging to enhance intestinal gas and food transit. Eating in an upright minimizes air and allows for efficient downward movement of contents through the digestive tract, while avoiding lying down immediately post-meal—ideally waiting 2 to 3 hours—prevents gas retention that occurs more readily in the . This simple adjustment can significantly reduce the likelihood of postprandial distension in susceptible individuals. Avoiding certain habits that introduce excess gas or fermentable substances is essential for bloating prophylaxis. Limiting or eliminating carbonated beverages, such as sodas and sparkling waters, curbs the ingestion of , which directly contributes to increased intraluminal pressure and bloating. Similarly, restricting artificial sweeteners like , commonly found in sugar-free gums and candies, prevents osmotic effects in the gut that lead to , gas , and bloating, particularly in those with sensitivities. To personalize these avoidances, maintaining a and symptom enables individuals to identify specific triggers, facilitating tailored adjustments that enhance prevention efficacy. Integrating short routines into daily life can proactively stimulate gut motility and avert bloating episodes. Engaging in a 10-minute walk after meals promotes and aids the digestive process, reducing postprandial gas accumulation. Complementing this, establishing timed bathroom habits—such as responding promptly to the urge to defecate and aiming for regularity, perhaps by sitting for 10 to 15 minutes at consistent times—helps prevent , thereby minimizing bloating from . A 2020 observational study indicated that increasing to achieve approximately 9500 daily steps can reduce the severity of gastrointestinal symptoms by 50% in younger individuals with (IBS), underscoring the value of such prophylactic habits for short-term prevention.

Long-Term Strategies

Long-term prevention of bloating focuses on sustainable changes that support gastrointestinal and minimize recurrent episodes. Incorporating regular , such as at least 150 minutes of moderate per week, enhances gut motility and reduces the overall incidence of bloating. Gradually increasing dietary fiber intake to 25–30 grams per day, combined with adequate hydration, promotes regular bowel movements and prevents constipation-related distension, though sudden increases should be avoided to limit initial gas production. Additionally, managing chronic stress through practices like mindfulness meditation or yoga can mitigate visceral hypersensitivity and gut-brain axis disruptions that contribute to bloating perception over time.

References

  1. [1]
    Symptoms & Causes of Gas in the Digestive Tract - NIDDK
    Bloating is a feeling of fullness or swelling in your abdomen, or belly. If your abdomen becomes larger than usual, doctors call this distention. Only about ...
  2. [2]
    Bloated Stomach: Causes, Tips to Reduce & When to be Concerned
    Sep 10, 2021 · Bloating is usually a digestive issue, though hormones and stress also play a part. Sometimes there is an underlying medical condition.
  3. [3]
    Pathophysiology, Evaluation, and Treatment of Bloating - NIH
    The goal of this paper is to review the pathophysiology, evaluation, and treatment of bloating and abdominal distention.
  4. [4]
    Bloating and Abdominal Distension: Clinical Approach and ... - NIH
    Mar 16, 2019 · Functional abdominal bloating is a subjective sensation that is commonly associated with an objective abdominal distension.
  5. [5]
    Bloating and Distension: Definitions and Causes - Rome Foundation
    Bloating is a sensation of gassiness (“I feel gassy”), trapped gas, or a feeling feeling of your abdomen being distended or swollen.
  6. [6]
    Gut Feelings Week: Dyspepsia and Navigating Nineteenth-Century ...
    May 26, 2017 · Dyspepsia (as dyſpepſy) first made an appearance in an English-language publication in 1661, but it was not until the 1780s that it appeared in ...
  7. [7]
  8. [8]
    Abdominal Bloating and Excessive Gas - Approach to the Patient
    Sep 24, 2024 · Bloating refers to a sensation of abdominal fullness, pressure, or trapped gas, whereas distention is a measurable increase in abdominal girth.
  9. [9]
    Prevalence and Associated Factors of Bloating - PubMed
    Jun 12, 2023 · Nearly 18% of the general population experience bloating at least once per week. Reported bloating prevalence is lower in older age groups, is ...
  10. [10]
    Prevalence and Associated Factors of Bloating - Gastroenterology
    Jun 12, 2023 · Nearly 18% of the worldwide population experience bloating at least once per week. Prevalence is lower in older age, most common in women, ...
  11. [11]
    Clinical Dimensions of Bloating in Functional Gastrointestinal ...
    Abdominal bloating is a common symptom affecting up to 76% of patients with functional gastrointestinal disorders (FGIDs) and 6–13% of the general population ...
  12. [12]
    Prevalence, Characteristics, and Impact of Bloating Symptoms in ...
    More than 80% of the patients participating in our study reported bloating symptoms, with significantly higher prevalence in women (87.4%) than in men (70.4%) ...
  13. [13]
    Mood symptoms and gut function across the menstrual cycle in ...
    As many as 73 % of menstruators report premenstrual GI symptoms, with symptoms such as abdominal pain, diarrhea, bloating, constipation, and nausea among the ...
  14. [14]
    The Western Diet and Bloating - News-Medical
    Mar 30, 2020 · A Western diet can have detrimental effects on our gut microbiota and is associated with an increased risk of bloating and functional digestive ...
  15. [15]
    COVID-19 Pandemic Linked to Surge in Digestive Disorders, New ...
    Jun 27, 2025 · Cedars-Sinai researchers have identified a potential link between pandemic-related stress and a rise in gut issues, according to a new study ...
  16. [16]
    The Prevalence and Burden of Disorders of Gut-Brain Interaction ...
    Jul 30, 2025 · The increase in DGBI prevalence after the COVID-19 pandemic was consistent in both sexes separately, and in all age groups. In males, the ...
  17. [17]
    Obesity is associated with increased risk of gastrointestinal symptoms
    Alternatively, excess food intake may cause gastrointestinal (GI) symptoms in obese patients. We evaluated the relationship between body mass index (BMI) and ...Missing: factors | Show results with:factors
  18. [18]
    Prevalence and risk factors for abdominal bloating and visible ... - NIH
    No evidence exists to show that bloating is related to age18 or parity. The risk factors for bloating and distention as well as the factors that distinguish ...
  19. [19]
    Prevalence and Associated Factors of Bloating - PubMed Central - NIH
    Nearly 18% of the general population experience bloating at least once per week. Reported bloating prevalence is lower in older age groups, is most common ...Missing: peak | Show results with:peak
  20. [20]
    Multicultural Aspects in Functional Gastrointestinal Disorders (FGIDs)
    This article highlights the importance of cross-cultural competence in clinical medicine and research.Missing: industrialized | Show results with:industrialized
  21. [21]
    Understanding and managing chronic abdominal bloating and ...
    Apr 17, 2021 · The list of possible causes includes organic, pathological conditions, disorders of gut-brain interaction and an abnormal viscerosomatic reflex.
  22. [22]
    Gas and Bloating - PMC - NIH
    Gaseous symptoms including eructation, flatulence, and bloating occur as a consequence of excess gas production, altered gas transit, or abnormal perception ...Gas And Bloating · Pathogenesis Of Gas And... · Functional Bowel Disorders
  23. [23]
    Responsiveness and interpretation of a symptom severity ... - PubMed
    The PAGI-SYM includes 6 subscales: heartburn/regurgitation, fullness/early satiety, nausea/vomiting, bloating, upper abdominal pain, and lower abdominal pain.
  24. [24]
    Psychological factors may affect the quality of life in irritable bowel ...
    Mar 26, 2024 · More than 40% of IBS patients were found to suffer from varying degrees of anxiety or depression, and anxiety (r = −0.564) and depression (r = − ...
  25. [25]
    Intestinal gas dynamics: mechanisms and clinical relevance - PMC
    Hence the volume of gas depends on diet, and most subjects may experience flatulence after eating foods rich in fermentable residues, such as beans. The amount ...
  26. [26]
  27. [27]
    SMALL INTESTINE TRANSIT TIME IN THE NORMAL SMALL ...
    Eighty-three per cent of the cases had a transit time of less than 2 hours, and the mean transit time was 84 minutes. The transit time pattern was compared ...
  28. [28]
    Temporal relationships between wall motion, intraluminal pressure ...
    Dec 30, 2010 · The level of the outflow was set 2–4 cm above the isolated intestinal segment to provide constant backpressure (corre- sponding to 1.5–2.9 mmHg) ...
  29. [29]
    Hydrogen Breath Test: What Is It, How To Prep & Results
    The hydrogen breath test is used to diagnose gastrointestinal conditions. It can identify common digestive problems such as lactose intolerance and SIBO ...Missing: peaks | Show results with:peaks
  30. [30]
    Interpreting the Lactulose Breath Test for the Diagnosis of Small ...
    A positive lactulose breath test (LBT) for small intestinal bacterial overgrowth requires an initial peak value of hydrogen within 100 minutes of lactulose ...
  31. [31]
    Biomarkers for visceral hypersensitivity in patients with irritable ...
    Jul 3, 2017 · A total of 167 IBS patients underwent a rectal barostat procedure to assess visceral sensitivity to pain. Based on the outcome, patients ...Abstract · MATERIALS AND METHODS · RESULTS · DISCUSSION
  32. [32]
    Are Bloating and Abdominal Distention Attributed to Gas Production ...
    Oct 7, 2013 · This study showed that both gas production and visceral hypersensitivity contribute to bloating and borborygmi, but not distention.
  33. [33]
    The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome
    Transcutaneous electrical acustimulation can reduce visceral perception in patients with the irritable bowel syndrome: a pilot study.
  34. [34]
    BLOATING IN GASTROPARESIS: SEVERITY, IMPACT, AND ...
    Bloating is prevalent in gastroparesis and is severe in many individuals. Bloating severity relates to female gender, body weight, and intensity of other ...
  35. [35]
    Gastroparesis - Symptoms and causes - Mayo Clinic
    Sep 6, 2024 · Gastroparesis is a condition in which the muscles in the stomach don't move food as they should for it to be digested.Missing: pooling | Show results with:pooling
  36. [36]
    Rome IV Criteria - Rome Foundation
    Recurrent bloating and/or distension occurring on average at least 1 day/week; abdominal bloating and/or distension predominates over other symptoms. ** There ...ROME IV Criteria Booklet · About the Rome Foundation · Rome V, DGBI 5th EditionMissing: transit | Show results with:transit
  37. [37]
    The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
    The microbiota, the gut, and the brain communicate through the microbiota-gut-brain axis in a bidirectional way that involves the autonomic nervous system.How the Microbiota... · The Vagus Nerve in the... · Stress, Vagus Nerve, and the...Missing: dysregulation bloating
  38. [38]
    Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and ...
    Mar 13, 2018 · In this review article, we discuss various functions of the vagus nerve which make it an attractive target in treating psychiatric and gastrointestinal ...Missing: dysregulation | Show results with:dysregulation
  39. [39]
    Mechanisms of Stress-induced Visceral Pain - PMC - PubMed Central
    Jan 1, 2018 · Evidence suggests that long-term stress facilitates visceral pain through sensitization of pain pathways and promotes chronic visceral pain disorders.
  40. [40]
    Mechanisms of hypersensitivity in IBS and functional disorders
    Jan 3, 2007 · Visceral hypersensitivity is currently the leading hypothesis to explain irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs).
  41. [41]
    Monash University
    The team used this low FODMAP diet in the first research studies which showed that a low FODMAP diet reduces symptoms in people with Irritable Bowel Syndrome ( ...
  42. [42]
    How important is fructose breath testing in the FODMAP approach?
    A blog about the poor reliability of fructose breath testing by Monash FODMAP | The experts in diet for IBS.
  43. [43]
    Efficacy of the low FODMAP diet for treating irritable bowel syndrome
    Studies show the low FODMAP diet consistently improves IBS symptoms, with up to 86% of patients experiencing improvement. Evidence supports its efficacy.
  44. [44]
    Lactose Intolerance - StatPearls - NCBI Bookshelf
    Aug 6, 2025 · This condition primarily affects adolescents and young adults, with equal prevalence across sexes. Globally, 65% to 70% of the population ...
  45. [45]
    Definition & Facts for Lactose Intolerance - NIDDK
    Lactose intolerance is a condition in which you have digestive symptoms—such as bloating, diarrhea, and gas—after you consume foods or drinks that contain ...
  46. [46]
    Is Fructose Malabsorption a Cause of Irritable Bowel Syndrome? - NIH
    Fructose malabsorption leads to osmotic diarrhea as well as gas and bloating due to fermentation in the colon. A low-fructose diet has been found to improve IBS ...
  47. [47]
    Belching, gas and bloating: Tips for reducing them - Mayo Clinic
    Bloating: Common but not fully understood. Bloating is a sensation of having a full stomach. Distension is a visible or measurable increase in belly size.Missing: definition | Show results with:definition
  48. [48]
    Aerophagia (Air Swallowing): Symptoms, Causes & Treatment
    Aug 16, 2024 · Aerophagia involves swallowing so much air that it collects in your gut, producing unpleasant symptoms. It may cause excessive burping or farting, bloating and ...
  49. [49]
    Dietary fiber: Essential for a healthy diet - Mayo Clinic
    High-fiber foods are good for your health. But adding too much fiber too quickly can lead to gas, bloating and cramping. Add fiber to your diet slowly over a ...Dietary Fiber: Essential For... · Your Best Fiber Choices · Fiber Supplements And...Missing: osmotic | Show results with:osmotic
  50. [50]
    Effects of High-Fiber Diets and Macronutrient Substitution on Bloating
    The prevalence of bloating at baseline and at the end of the carbohydrate-rich, protein-rich, and unsaturated fat-rich diet period was 18%, 24%, 33%, and 30%, ...Missing: incidence | Show results with:incidence
  51. [51]
    Celiac Disease - StatPearls - NCBI Bookshelf - NIH
    Feb 4, 2025 · Lactose intolerance, which may cause abdominal cramping, bloating, gas, and diarrhea, can occur in celiac disease due to villous atrophy but ...
  52. [52]
    Coeliac disease in irritable bowel syndrome (Rome III) in ... - PubMed
    Main symptoms of patients were diarrhoea (11/20), bloating (10/20) and abdominal distension (6/20). Thirteen (10.5%) patients were found to have positive IgA ...
  53. [53]
    Epidemiology of small intestinal bacterial overgrowth - PMC
    Tests for SIBO were positive in 43% of patients with functional abdominal bloating/distention[41] (although this proportion reached 68% in another study[42]), ...
  54. [54]
    Gastric Outlet Obstruction - StatPearls - NCBI Bookshelf
    Feb 15, 2025 · Gastric outlet obstruction (GOO) is a clinical syndrome that presents with various symptoms, including abdominal pain, postprandial vomiting ...Continuing Education Activity · Etiology · Evaluation · Treatment / Management
  55. [55]
    Link between hypothyroidism and small intestinal bacterial overgrowth
    GI motility is disturbed in hypothyroidism, which can lead to SIBO. SIBO may be responsible for chronic GI symptoms in these patients.
  56. [56]
    Ovarian cancer - Symptoms and causes - Mayo Clinic
    May 2, 2025 · Abdominal bloating or swelling ... The changes tell the cells to grow and multiply quickly, creating a mass (tumor) of cancer cells.
  57. [57]
    Ascites - StatPearls - NCBI Bookshelf - NIH
    History and Physical ... Patients typically report progressive abdominal distension that may be painless or associated with abdominal discomfort, weight gain, ...Missing: bloating | Show results with:bloating
  58. [58]
    Giardia infection (giardiasis) - Symptoms & causes - Mayo Clinic
    Sep 20, 2025 · It infects part of the digestive system called the small intestine. Symptoms include stomach cramps, bloating, upset stomach and loose stools.
  59. [59]
    C. difficile infection - Symptoms and causes - Mayo Clinic
    Sep 1, 2023 · Some people have loose stools during or shortly after antibiotic therapy. This may be caused by C. difficile infection. Make a health care ...
  60. [60]
    Pancreatic Insufficiency - StatPearls - NCBI Bookshelf - NIH
    Sep 14, 2025 · Lipase inactivation occurs early in the disease, so fat malabsorption typically precedes carbohydrate and protein malabsorption, resulting in ...
  61. [61]
    Endo Belly: What Is It and Why Does It Happen?—A Narrative Review
    Endo belly is primarily associated with endometriosis; the bloating and abdominal discomfort in endo belly are often linked to the menstrual cycle and the ...
  62. [62]
    Gas, Bloating, and Belching: Approach to Evaluation and Management
    Mar 1, 2019 · Gas, bloating, and belching are associated with a variety of conditions but are most commonly caused by functional gastrointestinal disorders.
  63. [63]
    Reliability and validity of the Gastrointestinal Symptom Rating Scale ...
    The GSRS is a disease-specific instrument of 15 items combined into five symptom clusters depicting Reflux, Abdominal pain, Indigestion, Diarrhoea and ...
  64. [64]
    Abdominal Examination - StatPearls - NCBI Bookshelf - NIH
    Following a quick assessment, the abdominal examination consists of 4 basic components—inspection, palpation, percussion, and auscultation. Inspection of the ...
  65. [65]
    Irritable Bowel Syndrome - StatPearls - NCBI Bookshelf
    Sep 15, 2025 · Irritable bowel syndrome (IBS) is a common, chronic disorder of gut-brain interaction characterized by recurrent abdominal pain and altered ...Irritable Bowel Syndrome · History And Physical · Treatment / Management
  66. [66]
    Effects of physical activity on symptoms of irritable bowel syndrome
    After completing the exercise cycle, the incidence of bloating decreased by 40%. Its severity was assessed using a scale of 1–100, where 100 meant very severe ...
  67. [67]
    Meditation and Yoga for Irritable Bowel Syndrome: A Randomized ...
    Proposed mechanisms of action for yoga target the brain-gut axis directly by reducing sympathetic activity, increasing parasympathetic activity, and ...
  68. [68]
    6 things you can do to prevent bloating | UCLA Health
    Apr 29, 2024 · If you think your bloating may be tied to overeating, try eating smaller meals more frequently.
  69. [69]
    Gas & Bloating: Natural Remedies - Brigham and Women's Hospital
    The abdomen doesn't get physically bigger until its volume increases by one quart, so the bloated feeling may occur, but the abdomen is not distended. ...Missing: daily | Show results with:daily
  70. [70]
    Bloating 101: Why You Feel Bloated - WebMD
    Feb 14, 2024 · If you often experience bloating caused by gas, avoid these habits that make you swallow more air: drinking through a straw; chewing gum ...Keep Bloating At Bay · Reducing Gassiness · Avoid Bloat-Inducing Foods<|separator|>
  71. [71]
    FODMAP Diet: What You Need to Know | Johns Hopkins Medicine
    “We recommend following the elimination portion of the diet for only two to six weeks,” says Veloso. “This reduces your symptoms and if you have SIBO, it can ...Missing: 4-6 | Show results with:4-6
  72. [72]
    Probiotics - Health Professional Fact Sheet
    Mar 25, 2025 · They continue to recommend using either LGG (1 to 6 × 109 CFU) or the combination of Bifidobacterium infantis, Bifidobacterium lactis, and ...
  73. [73]
    Comparison of the Effectiveness of Mindfulness-Based Stress ... - NIH
    The aim of this research was to compare the effectiveness of mindfulness-based stress reduction and compassion-focused on the severity of digestive symptoms
  74. [74]
    Abdominal Bloating: Pathophysiology and Treatment - PMC
    Bloating is defined as subjective discomfort by patient's sensation of intestinal gas; otherwise, abdominal distension is a visible increase in abdominal girth.
  75. [75]
    Antispasmodics for Chronic Abdominal Pain - PubMed Central - NIH
    In 2 randomized, placebo-controlled studies, dicyclomine improved symptoms of IBS ... bloating in irritable bowel syndrome: A randomized, placebo ...
  76. [76]
    Treatment of the irritable bowel syndrome with Bentyl (dicyclomine ...
    Dicyclomine hydrochloride 40 mg 4 times a day is superior to placebo in improving the overall condition of the patient, decreasing abdominal pain, decreasing ...
  77. [77]
    A Review of Pharmacologic and Non-Pharmacologic Therapies in ...
    Nov 18, 2024 · Three controlled RCTs, including two phase 3 trials, demonstrated that tenapanor significantly improved stool frequency, abdominal pain, and ...<|control11|><|separator|>
  78. [78]
    Simethicone - StatPearls - NCBI Bookshelf
    Adults: 40 to 125 mg orally four times daily as needed after meals and at bedtime; the maximum daily dose is 500 mg. Children ages 2 to 12 years: 40 mg ...
  79. [79]
    Does Beano prevent gas? A double-blind crossover study of oral ...
    Results: The number of flatulence events per hour was significantly less in the group treated with alpha-galactosidase than placebo over the 6-hour follow-up ...Missing: evidence | Show results with:evidence
  80. [80]
    Efficacy and tolerability of α-galactosidase in treating gas-related ...
    Sep 24, 2013 · This randomized placebo-controlled study provides evidence that oral α-galactosidase can improve gas-related symptoms in children and ...
  81. [81]
    ACG Clinical Guideline: Gastroparesis - PMC - PubMed Central
    Regulatory authorities issued restrictions and recommendations regarding long-term use of metoclopramide at oral doses exceeding 10 mg 3–4 times daily because ...
  82. [82]
    Linaclotide (Linzess) for Irritable Bowel syndrome With Constipation ...
    DOSAGE AND ADMINISTRATION. The approved dose of linaclotide is one 290-mcg capsule once daily in adults with IBS–C and one 145-mcg capsule once daily in ...
  83. [83]
    Review article: linaclotide for the management of irritable bowel ...
    Clinical trial data demonstrate that linaclotide improves abdominal symptoms (pain, bloating) and bowel symptoms (constipation) compared with placebo in ...
  84. [84]
    Polyethylene Glycol - StatPearls - NCBI Bookshelf - NIH
    The patients in the PEG group also proclaimed a better quality of life, reduced pain, less bloating, and alleviation of constipation symptoms.[3]. Non-FDA ...
  85. [85]
    Use of rifaximin in gastrointestinal and liver diseases - PMC - NIH
    High doses of rifaximin (1200 or 1600 mg/d) lead to a significant improvement in terms of therapeutic efficacy and SIBO eradication without increasing the ...
  86. [86]
  87. [87]
    12 Proven Ways to Reduce or Stop Bloating - Healthline
    May 21, 2024 · 1. Identify the cause of bloating · 2. Limit foods and activities that trigger bloating · 3. Check for lactose intolerance · 4. Support regular ...
  88. [88]
    Water consumption and prevalence of irritable bowel syndrome ...
    Jan 24, 2020 · Water intake might be associated with improvement of IBS through affecting GI function. Water intake might improve constipation among IBS-C ...
  89. [89]
    Constipation - Diagnosis and treatment - Mayo Clinic
    Apr 15, 2025 · Drink plenty of water. Drink water and beverages without caffeine. This keeps stools soft and prevents bloating and gas that can happen with ...Missing: bathroom | Show results with:bathroom
  90. [90]
    Influence of body posture on intestinal transit of gas - PMC - NIH
    Body posture has a significant influence on intestinal gas propulsion: transit is faster in the upright position than when supine.
  91. [91]
    What's Causing My Abdominal Bloating and Nausea? - Healthline
    Jan 3, 2017 · Resting in an upright position can reduce abdominal bloating and nausea related to acid reflux. This position reduces the acid's flow up your ...Missing: posture | Show results with:posture
  92. [92]
    Mayo Clinic Q and A: Food to reduce bloating
    Sep 12, 2023 · Instead, drink still or flat water or try peppermint, chamomile or ginger tea after meals, which can help promote digestion and soothe your gut.
  93. [93]
    Artificial sweeteners and other sugar substitutes - Mayo Clinic
    Jan 10, 2023 · Sugar alcohols, stevia and luo han guo can cause bloating, gas and diarrhea. The amount of sugar alcohol that causes these symptoms varies from ...
  94. [94]
    What Is Sorbitol? Benefits, Uses, Side Effects, and More - Healthline
    Sep 25, 2020 · Consuming sorbitol or other sugar alcohols in large amounts can cause bloating and diarrhea in some people, especially if you're not used to ...
  95. [95]
    Food-symptom diaries can generate personalized lifestyle advice for ...
    Diaries of GI symptoms, food intake, and psychological distress can lead to meaningful personalized lifestyle advice in subsets of patients.Missing: track | Show results with:track
  96. [96]
    Supporting Patient-Provider Collaboration to Identify Individual ... - NIH
    This work examines patient-provider collaboration using patient-generated food and symptom journals to identify nutrients that trigger an individual patient's ...Missing: diary | Show results with:diary
  97. [97]
    The effect of a short-term physical activity after meals on ... - NIH
    The present study aims to compare the effect of a short duration postprandial walking and prokinetic medications on bloating reported by healthy individuals ...
  98. [98]
    Constipation - Symptoms and causes - Mayo Clinic
    Apr 15, 2025 · Drink enough fluids. · Eat enough dietary fiber. · Exercise regularly. · Use the toilet when there's an urge to pass stool.Missing: habits | Show results with:habits
  99. [99]
    What Not to Do When You're Constipated - WebMD
    Mar 17, 2024 · Avoid the toilet.​​ When you're constipated, your body may need more time in the bathroom, not less. Try to sit on the toilet for 15 minutes at ...
  100. [100]
    The effects of locomotor activity on gastrointestinal symptoms ... - NIH
    May 29, 2020 · Based on our findings, increasing the daily step count to 9500 steps from 4000 steps will result in 50% reduction in the severity of symptoms.